Discover
ASHPOfficial
ASHPOfficial
Author: American Society of Health-System Pharmacists©
Subscribed: 122Played: 7,604Subscribe
Share
© Copyright 2025 All rights reserved.
Description
ASHPOfficial is the premier podcast of ASHP and the collective voice of our 60,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
1255 Episodes
Reverse
Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists’ role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.






Wow, why did she make an internal program sound like an advertisement?
The increase of the duties and responsibilities of pharmacy technicians have quickly outpaced pay and even education in some states, therefore you have the reason for your workforce shortage. I understand the problem of pharmacies lacking monetary resources to increase pay, but something needs to change and that's not more duties.